Effects of dexamethasone treatment on bone and collagen turnover in preterm infants with chronic lung disease

被引:20
作者
Crofton, PM
Shrivastava, A
Wade, JC
Stephen, R
Kelnar, CJH
McIntosh, N
Lyon, AJ
机构
[1] Royal Hosp Sick Children, Dept Paediat Biochem, Edinburgh EH9 1LF, Midlothian, Scotland
[2] Univ Edinburgh, Dept Child Life & Hlth, Edinburgh, Midlothian, Scotland
[3] Royal Infirm, Edinburgh, Midlothian, Scotland
关键词
D O I
10.1203/00006450-200008000-00007
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Dexamethasone is used commonly in the treatment of chronic lung disease of prematurity, but there are concerns about possible deleterious effects on growth and bone. Our aim in this study was to examine the effects of dexamethasone treatment on bone and collagen turnover in preterm infants. Bone-specific alkaline phosphatase, the C-terminal propeptide of type I collagen (PICP, reflecting whole-body type I collagen synthesis), and the N-terminal propeptide of type III procollagen (P3NP, reflecting soft tissue collagen turnover), together with the C-terminal telopeptide of type I collagen (ICTP), urinary pyridinoline (Pyd), and deoxypyridinoline (all markers of collagen breakdown) were measured at weekly intervals over the first 12 wk of life in 14 preterm infants with chronic lung disease treated with dexamethasone. Results were expressed as SD scores relative to preterm control infants not treated with dexamethasone. PICP, P3NP, ICTP, and Pyd all showed marked decreases (-2.1 to -3.7 SD scores) during the first week of treatment (p < 0.001), returning to pretreatment levels after stopping dexamethasone. In the group as a whole, these collagen markers were negatively correlated with dexamethasone dose (p, < 0.0001); negative correlations were also seen in most individual babies, although the slopes of individual regression lines varied by a factor of 2. Weight gain at 12 wk was correlated with PICP, expressed as the mean SD score over 12 wk for each baby, (r = 0.69, p < 0.01) but not with other markers or cumulative dose of dexamethasone. We conclude that dexametbasone markedly suppressed collagen turnover in preterm infants in a dose-dependent fashion, although some babies were more affected than others. The degree of suppression of type I collagen synthesis was a strong independent predictor of overall weight gain over the first 12 wk of life.
引用
收藏
页码:155 / 162
页数:8
相关论文
共 28 条
[1]  
BARON J, 1992, AM J PHYSIOL, V263, pE489
[2]   QUANTITATIVE-ANALYSIS OF THE PYRIDINIUM CROSSLINKS OF COLLAGEN IN URINE USING ION-PAIRED REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
BLACK, D ;
DUNCAN, A ;
ROBINS, SP .
ANALYTICAL BIOCHEMISTRY, 1988, 169 (01) :197-203
[3]   MICROVASCULAR INVASION OF RABBIT GROWTH PLATE CARTILAGE AND THE INFLUENCE OF DEXAMETHASONE [J].
BROWN, RA ;
REES, JA ;
MCFARLAND, CD ;
LEWINSON, D ;
ALI, SY .
BONE AND MINERAL, 1990, 9 (01) :35-47
[4]   Mechanisms of glucocorticoid action in bone: Implications to glucocorticoid-induced osteoporosis [J].
Canalis, E .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (10) :3441-3447
[5]  
CROFTON PM, 1987, CLIN CHEM, V33, P1778
[6]  
CROFTON PM, 1987, CLIN CHEM, V33, P1783
[7]   Bone and collagen markers in preterm infants: Relationship with growth and bone mineral content over the first 10 weeks of life [J].
Crofton, PM ;
Shrivastava, A ;
Wade, JC ;
Stephen, R ;
Kelnar, CJH ;
Lyon, AJ ;
McIntosh, N .
PEDIATRIC RESEARCH, 1999, 46 (05) :581-587
[8]  
Crofton PM, 1998, INT J CLIN PRACT, V52, P557
[9]   MECHANISMS OF GLUCOCORTICOID ACTION IN BONE-CELLS [J].
DELANY, AM ;
DONG, Y ;
CANALIS, E .
JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, 56 (03) :295-302
[10]   GLUCOCORTICOID-INDUCED OSTEOPOROSIS [J].
GENNARI, C .
CLINICAL ENDOCRINOLOGY, 1994, 41 (03) :273-274